These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26599081)

  • 41. The proline-rich P65 protein of Mycoplasma pneumoniae is a component of the Triton X-100-insoluble fraction and exhibits size polymorphism in the strains M129 and FH.
    Proft T; Hilbert H; Layh-Schmitt G; Herrmann R
    J Bacteriol; 1995 Jun; 177(12):3370-8. PubMed ID: 7768845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.
    Shaw BM; Daubenspeck JM; Simmons WL; Dybvig K
    FEMS Microbiol Lett; 2013 Jan; 338(2):155-60. PubMed ID: 23190331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.
    Simmons WL; Dybvig K
    Infect Immun; 2007 Aug; 75(8):3696-9. PubMed ID: 17517864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Never say never again: protein glycosylation in pathogenic bacteria.
    Benz I; Schmidt MA
    Mol Microbiol; 2002 Jul; 45(2):267-76. PubMed ID: 12123443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sialic acid-dependent adhesion of Mycoplasma pneumoniae to purified glycoproteins.
    Roberts DD; Olson LD; Barile MF; Ginsburg V; Krivan HC
    J Biol Chem; 1989 Jun; 264(16):9289-93. PubMed ID: 2470754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
    Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
    Infect Immun; 1998 Oct; 66(10):4804-10. PubMed ID: 9746582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterization of Mycoplasma arthritidis membrane lipoprotein MAA1.
    Washburn LR; Miller EJ; Weaver KE
    Infect Immun; 2000 Feb; 68(2):437-42. PubMed ID: 10639401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.
    Simmons WL; Bolland JR; Daubenspeck JM; Dybvig K
    J Bacteriol; 2007 Mar; 189(5):1905-13. PubMed ID: 17142389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC.
    Sartain MJ; Belisle JT
    Glycobiology; 2009 Jan; 19(1):38-51. PubMed ID: 18842962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sweet new world: glycoproteins in bacterial pathogens.
    Schmidt MA; Riley LW; Benz I
    Trends Microbiol; 2003 Dec; 11(12):554-61. PubMed ID: 14659687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bacterial cell-envelope glycoconjugates.
    Messner P; Schäffer C; Kosma P
    Adv Carbohydr Chem Biochem; 2013; 69():209-72. PubMed ID: 24274370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis.
    Dybvig K; French CT; Voelker LL
    J Bacteriol; 2000 Aug; 182(15):4343-7. PubMed ID: 10894746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adaptive surface variation in mycoplasmas.
    Wise KS
    Trends Microbiol; 1993 May; 1(2):59-63. PubMed ID: 8044463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amino acid distributions around O-linked glycosylation sites.
    Wilson IB; Gavel Y; von Heijne G
    Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):529-34. PubMed ID: 2025231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemistry of S-layers.
    Messner P; Allmaier G; Schäffer C; Wugeditsch T; Lortal S; König H; Niemetz R; Dorner M
    FEMS Microbiol Rev; 1997 Jun; 20(1-2):25-46. PubMed ID: 9276927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry.
    Regula JT; Boguth G; Görg A; Hegermann J; Mayer F; Frank R; Herrmann R
    Microbiology (Reading); 2001 Apr; 147(Pt 4):1045-1057. PubMed ID: 11283300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for high affinity binding-protein dependent transport systems in gram-positive bacteria and in Mycoplasma.
    Gilson E; Alloing G; Schmidt T; Claverys JP; Dudler R; Hofnung M
    EMBO J; 1988 Dec; 7(12):3971-4. PubMed ID: 3208757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function.
    Edge AS
    Biochem J; 2003 Dec; 376(Pt 2):339-50. PubMed ID: 12974674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of two glycosylated components of Mycoplasma penetrans: a surface-exposed capsular polysaccharide and a glycolipid fraction.
    Neyrolles O; Brenner C; Prevost MC; Fontaine T; Montagnier L; Blanchard A
    Microbiology (Reading); 1998 May; 144 ( Pt 5)():1247-1255. PubMed ID: 9611799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein cleavage influences surface protein presentation in Mycoplasma pneumoniae.
    Berry IJ; Widjaja M; Jarocki VM; Steele JR; Padula MP; Djordjevic SP
    Sci Rep; 2021 Mar; 11(1):6743. PubMed ID: 33762641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.